{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:38:00Z","timestamp":1794512280443,"version":"4.9.1"},"publisher-location":"Cham","reference-count":115,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319253022","type":"print"},{"value":"9783319253046","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-25304-6_14","type":"book-chapter","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T05:02:00Z","timestamp":1451538120000},"page":"327-349","source":"Crossref","is-referenced-by-count":148,"title":["Antifungals: Mechanism of Action and Drug Resistance"],"prefix":"10.1007","author":[{"given":"Rajendra","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Haseeb","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet Kaur","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1128\/AAC.01653-05","volume":"50","author":"SV Balashov","year":"2006","unstructured":"Balashov SV, Park S, Perlin DS (2006) Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1. Antimicrob Agents Chemother 50:2058\u20132063","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3852\/08-163","volume":"101","author":"GF Bills","year":"2009","unstructured":"Bills GF, Platas G, Overy DP, Collado J, Fillola A, Jim\u00e9nez MR et al (2009) Discovery of the parnafungins, antifungal metabolites that inhibit mRNA polyadenylation, from the Fusarium larvarum complex and other Hypocrealean fungi. Mycologia 101:449\u2013472","journal-title":"Mycologia"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1874437001105010029","volume":"5","author":"A Bink","year":"2011","unstructured":"Bink A, Pellens K, Cammue BPA, Thevissen K (2011) Anti-Biofilm Strategies: how to Eradicate Candida Biofilms? Open Mycol J 5:29\u201338","journal-title":"Open Mycol J"},{"issue":"165","key":"14_CR4","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"G. D. Brown","year":"2012","unstructured":"Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC (2012) Hidden killers: human fungal infections. Sci Transl Med 4:165rv13","journal-title":"Science Translational Medicine"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/jac\/dks506","volume":"68","author":"EC Calabrese","year":"2013","unstructured":"Calabrese EC, Castellano S, Santoriello M, Sgherri C, Quartacci MF, Calucci L et al (2013) Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans. J Antimicrob Chemother 68:1111\u20131119","journal-title":"J Antimicrob Chemother"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CMR.00051-08","volume":"22","author":"RD Cannon","year":"2009","unstructured":"Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV et al (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22:291\u2013321","journal-title":"Clin Microbiol Rev"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1006\/bbrc.1993.1153","volume":"190","author":"JO Capobianco","year":"1993","unstructured":"Capobianco JO, Zakula D, Coen ML, Goldman RC (1993) Anti-Candida activity of cispentacin: the active transport by amino acid permeases and possible mechanisms of action. Biochem Biophys Res Commun 190:1037\u20131044","journal-title":"Biochem Biophys Res Commun"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1128\/AAC.45.6.1660-1670.2001","volume":"45","author":"MD Backer De","year":"2001","unstructured":"De Backer MD, Ilyina T, Ma XJ, Vandoninck S, Luyten WH, Vanden Bossche H (2001) Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob Agents Chemother 45:1660\u20131670","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1101\/gr.GR-1649R","volume":"11","author":"M Dean","year":"2001","unstructured":"Dean M, Andrey R, Rando A (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11:1156\u20131166","journal-title":"Genome Res"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"12612","DOI":"10.1074\/jbc.273.20.12612","volume":"273","author":"A Decottignies","year":"1998","unstructured":"Decottignies A, Grant AM, Nichols JW, De Wet H, McIntosh DB, Goffeau A (1998) ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J Biol Chem 273:12612\u201312622","journal-title":"J Biol Chem"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/AAC.00574-11","volume":"56","author":"S Dhamgaye","year":"2012","unstructured":"Dhamgaye S, Devaux F, Manoharlal R, Vandeputte P, Shah AH, Singh A et al (2012) In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2. Antimicrob Agents Chemother 56:495\u2013506","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"e104554","DOI":"10.1371\/journal.pone.0104554","volume":"9","author":"S Dhamgaye","year":"2014","unstructured":"Dhamgaye S, Devaux F, Vandeputte P, Khandelwal NK, Sanglard D, Mukhopadhyay G et al (2014) Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans. PLoS One 9:e104554","journal-title":"PLoS One"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1128\/AAC.42.9.2279","volume":"42","author":"JM Dom\u00ednguez","year":"1998","unstructured":"Dom\u00ednguez JM, Mart\u00edn JJ (1998) Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans. Antimicrob Agents Chemother 42:2279\u20132283","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/AAC.42.9.2274","volume":"42","author":"JM Dom\u00ednguez","year":"1998","unstructured":"Dom\u00ednguez JM, Kelly VA, Kinsman OS, Marriott MS, G\u00f3mez de las Heras F, Mart\u00edn JJ (1998) Sordarins: a new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts. Antimicrob Agents Chemother 42:2274\u20132278","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1130-1406(09)70004-X","volume":"26","author":"A Espinel-Ingroff","year":"2009","unstructured":"Espinel-Ingroff A (2009) Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005\u20132009). Rev Iberoam Micol 26:15\u201322","journal-title":"Rev Iberoam Micol"},{"key":"14_CR16","first-page":"889","volume":"1","author":"A Espinel-Ingroff","year":"2009","unstructured":"Espinel-Ingroff A, Canton E, Martin-Mazuelos E, Pem\u00e1n J (2009) Pharmacotherapy of Candida Infections with Echinocandins. Clin Med Ther 1:889\u2013897","journal-title":"Clin Med Ther"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/EC.00215-12","volume":"11","author":"SA Flowers","year":"2012","unstructured":"Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE et al (2012) Gain-of function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Eukaryot Cell 11:1289\u20131299","journal-title":"Eukaryot Cell"},{"issue":"1","key":"14_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1359-6446(99)01430-0","volume":"5","author":"Jennifer M Fostel","year":"2000","unstructured":"Fostel JM, Lartey PA (2000) Emerging novel antifungal agents. Drug Discov Today 5:25\u201332","journal-title":"Drug Discovery Today"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1128\/AAC.01677-13","volume":"58","author":"C Gallo-Ebert","year":"2014","unstructured":"Gallo-Ebert C, Donigan M, Stroke IL, Swanson RN, Manners MT, Francisco J et al (2014) Novel antifungal drug discovery based on targeting pathways regulating the fungus-conserved Upc2 transcription factor. Antimicrob Agents Chemother 58:258\u2013266","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.ijid.2011.10.004","volume":"16","author":"MA Garbati","year":"2012","unstructured":"Garbati MA, Alasmari FA, Al-Tannir MA, Tleyjeh IM (2012) The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review. Int J Infect Dis 16:e76\u2013e81","journal-title":"Int J Infect Dis"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1128\/AAC.01162-08","volume":"53","author":"G Garcia-Effron","year":"2009","unstructured":"Garcia-Effron G, Park S, Perlin DS (2009) Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother 53:112\u2013122","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000088141","volume":"9","author":"M Gaur","year":"2005","unstructured":"Gaur M, Choudhury D, Prasad R (2005) Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans. J Mol Microbiol Biotechnol 9:3\u201315","journal-title":"J Mol Microbiol Biotechnol"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/1471-2164-9-579","volume":"9","author":"M Gaur","year":"2008","unstructured":"Gaur M, Puri N, Manoharlal R, Rai V, Mukhopadhayay G, Choudhury D et al (2008) MFS transportome of the human pathogenic yeast Candida albicans. BMC Genomics 9:579","journal-title":"BMC Genomics"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1128\/AAC.38.9.2029","volume":"38","author":"MA Ghannoum","year":"1994","unstructured":"Ghannoum MA, Spellberg BJ, Ibrahim AS, Ritchie JA, Currie B, Spitzer ED et al (1994) Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. Antimicrob Agents Chemother 38:2029\u20132033","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2007.02.011","volume":"356","author":"J Golin","year":"2007","unstructured":"Golin J, Ambudkar SV, May L (2007) The yeast Pdr5p multidrug transporter: how does it recognize so many substrates? Biochem Biophys Res Commun 356:1\u20135","journal-title":"Biochem Biophys Res Commun"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.mib.2012.04.005","volume":"15","author":"NA Gow","year":"2012","unstructured":"Gow NA, Hube B (2012) Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol 15:406\u2013412","journal-title":"Curr Opin Microbiol"},{"key":"14_CR28","unstructured":"Gubbins PO, Anaissie E (2006) Overview of antifungal agents. Pharmacy practice news special edition 59\u201364"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"884","DOI":"10.7164\/antibiotics.50.884","volume":"50","author":"G Gunawardana","year":"1997","unstructured":"Gunawardana G, Rasmussen RR, Scherr M, Frost D, Brandt KD, Choi W et al (1997) Corynecandin: a novel antifungal glycolipid from Coryneum modonium. J Antibiot (Tokyo) 50:884\u2013886","journal-title":"J Antibiot (Tokyo)"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.7164\/antibiotics.51.837","volume":"51","author":"GH Harris","year":"1998","unstructured":"Harris GH, Shafiee A, Cabello MA, Curotto JE, Genilloud O, G\u00f6klen KE et al (1998) Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs. J Antibiot (Tokyo) 51:837\u2013844","journal-title":"J Antibiot (Tokyo)"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1128\/AAC.01102-09","volume":"54","author":"CJ Heilmann","year":"2010","unstructured":"Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschh\u00e4user J (2010) An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Antimicrob Agents Chemother 54:353\u2013359","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.fbr.2011.01.003","volume":"25","author":"J Heitman","year":"2011","unstructured":"Heitman J (2011) Microbial pathogens in the fungal kingdom. Fungal Biol Rev 25:48\u201360","journal-title":"Fungal Biol Rev"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/AAC.44.10.2693-2700.2000","volume":"44","author":"KW Henry","year":"2000","unstructured":"Henry KW, Nickels JT, Edlind TD (2000) Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 44:2693\u20132700","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/AAC.42.11.2863","volume":"42","author":"E Herreros","year":"1998","unstructured":"Herreros E, Martinez CM, Almela MJ, Marriott MS, De Las Heras FG, Gargallo-Viola D (1998) Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi. Antimicrob Agents Chemother 42:2863\u20132869","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/jac\/dkn075","volume":"61","author":"S Hodgetts","year":"2008","unstructured":"Hodgetts S, Nooney L, Al-Akeel R, Curry A, Awad S, Matthews R et al (2008) Efungumab and caspofungin: pre-clinical data supporting synergy. J Antimicrob Chemother 61:1132\u20131139","journal-title":"J Antimicrob Chemother"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1128\/AAC.00995-10","volume":"55","author":"SJ Hoot","year":"2011","unstructured":"Hoot SJ, Smith AR, Brown RP, White TC (2011) An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans. Antimicrob Agents Chemother 55:940\u2013942","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7164\/antibiotics.43.1","volume":"43","author":"T Iwamoto","year":"1990","unstructured":"Iwamoto T, Tsujii E, Ezaki M, Fujie A, Hashimoto S, Okuhara M et al (1990) FR109615, a new antifungal antibiotic from Streptomyces setonii. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J Antibiot (Tokyo) 43:1\u20137","journal-title":"J Antibiot (Tokyo)"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.chembiol.2008.02.016","volume":"15","author":"B Jiang","year":"2008","unstructured":"Jiang B, Xu D, Allocco J, Parish C, Davison J, Veillette K et al (2008) PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products. Chem Biol 15:363\u2013374","journal-title":"Chem Biol"},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1128\/AAC.02145-13","volume":"58","author":"C Jim\u00e9nez-Ortigosa","year":"2014","unstructured":"Jim\u00e9nez-Ortigosa C, Paderu P, Motyl MR, Perlin DS (2014) Enfumafungin derivative MK-3118 shows increased in vitro potency against clinical echinocandin-resistant Candida Species and Aspergillus species isolates. Antimicrob Agents Chemother 58:1248\u20131251","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1128\/AAC.01369-07","volume":"52","author":"H Kakeya","year":"2008","unstructured":"Kakeya H, Miyazaki Y, Senda H, Kobayashi T, Seki M, Izumikawa K et al (2008a) Efficacy of SPK-843, a novel polyene antifungal, in comparison with amphotericin B, liposomal amphotericin B, and micafungin against murine pulmonary aspergillosis. Antimicrob Agents Chemother 52:1868\u20131870","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1128\/AAC.01370-07","volume":"52","author":"H Kakeya","year":"2008","unstructured":"Kakeya H, Miyazaki Y, Senda H, Kobayashi T, Seki M, Izumikawa K et al (2008b) Efficacy of SPK-843, a novel polyene antifungal, in a murine model of systemic cryptococcosis. Antimicrob Agents Chemother 52:1871\u20131872","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7164\/antibiotics.46.247","volume":"46","author":"R Kaneto","year":"1993","unstructured":"Kaneto R, Chiba H, Agematu H, Shibamoto N, Yoshioka T, Nishida H et al (1993) Mer-WF3010, a new member of the papulacandin family. I. Fermentation, isolation and characterization. J Antibiot (Tokyo) 46:247\u2013250","journal-title":"J Antibiot (Tokyo)"},{"key":"14_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1179\/joc.2003.15.3.296","volume":"15","author":"AS Kantarcioglu","year":"2003","unstructured":"Kantarcioglu AS, Yucel A, Vidotto V (2003) In vitro activity of a new polyene SPK-843 against Candida spp, Cryptococcus neoformans and Aspergillus spp. clinical isolates. J Chemother 15:296\u2013298","journal-title":"J Chemother"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1128\/AAC.48.8.3064-3079.2004","volume":"48","author":"M Karababa","year":"2004","unstructured":"Karababa M, Coste AT, Rognon B, Bille J, Sanglard D (2004) Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother 48:3064\u20133079","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/mmy.39.1.109.116","volume":"39","author":"SK Katiyar","year":"2001","unstructured":"Katiyar SK, Edlind TD (2001) Identification and expression of multidrug resistance related ABC transporter genes in Candida krusei. Med Mycol 39:109\u2013116","journal-title":"Med Mycol"},{"key":"14_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7164\/antibiotics.51.41","volume":"51","author":"OS Kinsman","year":"1998","unstructured":"Kinsman OS, Chalk PA, Jackson HC, Middleton RF, Shuttleworth A, Rudd BA et al (1998) Isolation and characterisation of an antifungal antibiotic (GR135402) with protein synthesis inhibition. J Antibiot (Tokyo) 51:41\u201349","journal-title":"J Antibiot (Tokyo)"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1128\/AAC.00844-08","volume":"53","author":"A Kitamura","year":"2009","unstructured":"Kitamura A, Someya K, Hata M, Nakajima R, Takemura M (2009) Discovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesis. Antimicrob Agents Chemother 53:670\u2013677","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR48","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1128\/AAC.46.4.1046-1052.2002","volume":"46","author":"A Kohli","year":"2002","unstructured":"Kohli A, Smirti, Mukhopadhyay K, Rattan A, Prasad R (2002) In vitro low-level resistance to azole in Candida albicans is associated with changes in membrane fluidity and asymmetry. Antimicrob Agents Chemother 46:1046\u20131052","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.7164\/antibiotics.42.1749","volume":"42","author":"M Konishi","year":"1989","unstructured":"Konishi M, Nishio M, Saitoh K, Miyaki T, Oki T, Kawaguchi H (1989) Cispentacin, a new antifungal antibiotic. I. Production, isolation, physico-chemical properties and structure. J Antibiot (Tokyo) 42:1749\u20131755","journal-title":"J Antibiot (Tokyo)"},{"key":"14_CR50","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00438-004-0984-x","volume":"271","author":"H Kusch","year":"2004","unstructured":"Kusch H, Biswas K, Schwanfelder S, Engelmann S, Rogers PD, Hecker M et al (2004) A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Mol Genet Genomics 271:554\u2013565","journal-title":"Mol Genet Genomics"},{"key":"14_CR51","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/AAC.43.7.1725","volume":"43","author":"DC Lamb","year":"1999","unstructured":"Lamb DC, Maspahy S, Kelly DE, Manning NJ, Geber A, Bennett JE et al (1999) Purification, reconstitution, and inhibition of cytochrome P-450 sterol delta22-desaturase from the pathogenic fungus Candida glabrata. Antimicrob Agents Chemother 43:1725\u20131728","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.fgb.2009.10.007","volume":"47","author":"E Lamping","year":"2010","unstructured":"Lamping E, Baret PV, Holmes AR, Monk BC, Goffeau A, Cannon RD (2010) Fungal PDR transporters: phylogeny, topology, motifs and function. Fungal Genet Biol 47:127\u2013142","journal-title":"Fungal Genet Biol"},{"key":"14_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"A Lemke","year":"2005","unstructured":"Lemke A, Kiderlen AF, Kayser O (2005) Amphotericin B. Appl Microbiol Biotechnol 68:151\u2013162","journal-title":"Appl Microbiol Biotechnol"},{"key":"14_CR54","doi-asserted-by":"publisher","first-page":"149S","DOI":"10.1592\/phco.21.12.149S.34505","volume":"21","author":"RE Lewis","year":"2001","unstructured":"Lewis RE, Kontoyiannis DP (2001) Rationale for combination antifungal therapy. Pharmacotherapy 21:149S\u2013164S","journal-title":"Pharmacotherapy"},{"key":"14_CR55","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1128\/AAC.49.6.2226-2236.2005","volume":"49","author":"TT Liu","year":"2005","unstructured":"Liu TT, Lee REB, Barker KS, Lee RE, Wei L, Homayouni R et al (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49:2226\u20132236","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.clindermatol.2009.12.014","volume":"28","author":"R L\u00f3pez-Mart\u00ednez","year":"2010","unstructured":"L\u00f3pez-Mart\u00ednez R (2010) Candidosis, a new challenge. Clin Dermatol 28:178\u2013184","journal-title":"Clin Dermatol"},{"key":"14_CR57","doi-asserted-by":"publisher","first-page":"32709","DOI":"10.1074\/jbc.272.51.32709","volume":"272","author":"SM Mandala","year":"1997","unstructured":"Mandala SM, Thornton RA, Rosenbach M, Milligan J, Garcia-Calvo M, Bull HG et al (1997) Khafrefungin, a novel inhibitor of sphingolipid synthesis. J Biol Chem 272:32709\u201332714","journal-title":"J Biol Chem"},{"key":"14_CR58","doi-asserted-by":"publisher","first-page":"14942","DOI":"10.1074\/jbc.273.24.14942","volume":"273","author":"SM Mandala","year":"1998","unstructured":"Mandala SM, Thornton RA, Milligan J, Rosenbach M, Garcia-Calvo M, Bull HG et al (1998) Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase. J Biol Chem 273:14942\u201314949","journal-title":"J Biol Chem"},{"issue":"9","key":"14_CR59","doi-asserted-by":"publisher","first-page":"e1001126","DOI":"10.1371\/journal.ppat.1001126","volume":"6","author":"BE Mansfield","year":"2010","unstructured":"Mansfield BE, Oltean HN, Oliver BG, Hoot SJ, Leyde SE, Hedstrom L et al (2010) Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi. PLoS Pathog 6(9):e1001126","journal-title":"PLoS Pathog"},{"key":"14_CR60","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","volume":"145","author":"P Marichal","year":"1999","unstructured":"Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W et al (1999) Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145:2701\u20132713","journal-title":"Microbiology"},{"key":"14_CR61","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1128\/AAC.00303-10","volume":"54","author":"CM Martel","year":"2010","unstructured":"Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG et al (2010) A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B. Antimicrob Agents Chemother 54:3578\u20133583","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR62","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijantimicag.2009.04.011","volume":"34","author":"MH Miceli","year":"2009","unstructured":"Miceli MH, Bernardo SM, Lee SA (2009) In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Int J Antimicrob Agents 34:326\u2013332","journal-title":"Int J Antimicrob Agents"},{"key":"14_CR63","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1128\/AAC.01159-07","volume":"52","author":"J Mitsuyama","year":"2008","unstructured":"Mitsuyama J, Nomura N, Hashimoto K, Yamada E, Nishikawa H, Kaeriyama M et al (2008) In vitro and in vivo antifungal activities of T-2307, a novel arylamidine. Antimicrob Agents Chemother 52:1318\u20131324","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR64","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.42.7.1695","volume":"42","author":"H Miyazaki","year":"1998","unstructured":"Miyazaki H, Miyazaki Y, Geber A, Parkinson T, Hitchcock C et al (1998) Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob Agents Chemother 42:1695\u20131701","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR65","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/AAC.42.7.1819","volume":"42","author":"GP Moran","year":"1998","unstructured":"Moran GP, Sanglard D, Donnelly SM, Shanley DB, Sullivan DJ, Coleman DC (1998) Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 42:1819\u20131830","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR66","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","volume":"66","author":"F Morio","year":"2010","unstructured":"Morio F, Loge C, Besse B, Hennequin C, Le Pape P (2010) Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infect Dis 66:373\u2013384","journal-title":"Diagn Microbiol Infect Dis"},{"key":"14_CR67","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1046\/j.1365-2958.2001.02347.x","volume":"39","author":"CA Munro","year":"2001","unstructured":"Munro CA, Winter K, Buchan A, Henry K, Becker JM, Brown AJ et al (2001) Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity. Mol Microbiol 39:1414\u20131426","journal-title":"Mol Microbiol"},{"key":"14_CR68","doi-asserted-by":"publisher","first-page":"9809","DOI":"10.1074\/jbc.272.15.9809","volume":"272","author":"MM Nagiec","year":"1997","unstructured":"Nagiec MM, Nagiec EE, Baltisberger JA, Wells GB, Lester RL, Dickson RC (1997) Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. J Biol Chem 272:9809\u20139817","journal-title":"J Biol Chem"},{"key":"14_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10156-008-0653-9","volume":"15","author":"I Nishi","year":"2009","unstructured":"Nishi I, Sunada A, Toyokawa M, Asari S, Iwatani Y (2009) In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. J Infect Chemother 15:1\u20135","journal-title":"J Infect Chemother"},{"key":"14_CR71","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/jac\/42.6.755","volume":"42","author":"A Ogawa","year":"1998","unstructured":"Ogawa A, Hashida-Okado T, Endo M, Yoshioka H, Tsuruo T, Takesako K et al (1998) Role of ABC transporters in aureobasidin A resistance. Antimicrob Agents Chemother 42:755\u2013761","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR72","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.7164\/antibiotics.51.1081","volume":"51","author":"H Okada","year":"1998","unstructured":"Okada H, Kamiya S, Shiina Y, Suwa H, Nagashima M, Nakajima S et al (1998) BE-31405, a new antifungal antibiotic produced by Penicillium minioluteum. I. Description of producing organism, fermentation, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) 51:1081\u20131086","journal-title":"J Antibiot (Tokyo)"},{"key":"14_CR73","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1128\/AAC.49.12.4895-4902.2005","volume":"49","author":"JA Olson","year":"2005","unstructured":"Olson JA, Adler-Moore JP, Smith PJ, Proffitt RT (2005) Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Antimicrob Agents Chemother 49:4895\u20134902","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR74","doi-asserted-by":"publisher","first-page":"36304","DOI":"10.1074\/jbc.M110.142760","volume":"285","author":"S Pagant","year":"2010","unstructured":"Pagant S, Halliday JJ, Kougentakis C, Miller EA (2010) Intragenic suppressing mutations correct the folding and intracellular traffic of misfolded mutants of Yor1p, a eukaryotic drug transporter. J Biol Chem 285:36304\u201336314","journal-title":"J Biol Chem"},{"key":"14_CR75","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1128\/AAC.01557-07","volume":"52","author":"MP Pai","year":"2008","unstructured":"Pai MP, Samples ML, Mercier RC, Spilde MN (2008) Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations. Antimicrob Agents Chemother 52:2367\u20132376","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR76","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1021\/ja711209p","volume":"130","author":"CA Parish","year":"2008","unstructured":"Parish CA, Smith SK, Calati K, Zink D, Wilson K, Roemer T et al (2008) Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation. J Am Chem Soc 130:7060\u20137066","journal-title":"J Am Chem Soc"},{"key":"14_CR77","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1128\/AAC.49.8.3264-3273.2005","volume":"49","author":"S Park","year":"2005","unstructured":"Park S, Kelly R, Kahn JN, Robles J, Hsu MJ, Register E et al (2005) Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother 49:3264\u20133273","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR78","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1128\/EC.00315-06","volume":"6","author":"R Pasrija","year":"2007","unstructured":"Pasrija R, Banerjee D, Prasad R (2007) Structure and function analysis of CaMdr1p, a major facilitator superfamily antifungal efflux transporter protein of Candida albicans: identification of amino acid residues critical for drug\/H+ transport. Eukaryot Cell 6:443\u2013453","journal-title":"Eukaryot Cell"},{"key":"14_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","volume":"10","author":"DS Perlin","year":"2007","unstructured":"Perlin DS (2007) Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 10:121\u2013130","journal-title":"Drug Resist Updat"},{"key":"14_CR81","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2217\/fmb.11.19","volume":"6","author":"DS Perlin","year":"2011","unstructured":"Perlin DS (2011) Current perspectives on echinocandin class drugs. Future Microbiol 6:441\u2013457","journal-title":"Future Microbiol"},{"key":"14_CR82","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1128\/AAC.48.10.3959-3967.2004","volume":"48","author":"V Petraitis","year":"2004","unstructured":"Petraitis V, Petraitiene R, Kelaher AM, Sarafandi AA, Sein T, Mickiene D et al (2004) Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans. Antimicrob Agents Chemother 48:3959\u20133967","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR83","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-micro-092611-150111","volume":"66","author":"R Prasad","year":"2012","unstructured":"Prasad R, Goffeau A (2012) Yeast ATP-binding cassette transporters conferring multidrug resistance. Annu Rev Microbiol 66:39\u201363","journal-title":"Annu Rev Microbiol"},{"key":"14_CR84","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0074-7696(04)42005-1","volume":"242","author":"R Prasad","year":"2005","unstructured":"Prasad R, Kapoor K (2005) Multidrug resistance in yeast Candida. Int Rev Cytol 242:215\u2013248","journal-title":"Int Rev Cytol"},{"key":"14_CR85","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/BF00352101","volume":"27","author":"R Prasad","year":"1995","unstructured":"Prasad R, DeWergifosse P, Goffeau A, Balzi E (1995) Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27:320\u2013329","journal-title":"Curr Genet"},{"key":"14_CR86","first-page":"587","volume":"10","author":"T Prasad","year":"2010","unstructured":"Prasad T, Hameed S, Manoharlal R, Biswas S, Mukhopadhyay CK, Goswami SK et al (2010) Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans. FEMS Yeast Res 10:587\u2013596","journal-title":"FEMS Yeast Res"},{"key":"14_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1040841X.2014.974500","volume":"10","author":"ME Rodrigues","year":"2014","unstructured":"Rodrigues ME, Silva S, Azeredo J, Henriques M (2014) Novel strategies to fight Candida species infection. Crit Rev Microbiol 10:1\u201313","journal-title":"Crit Rev Microbiol"},{"issue":"5","key":"14_CR88","doi-asserted-by":"crossref","first-page":"a019703","DOI":"10.1101\/cshperspect.a019703","volume":"4","author":"T. Roemer","year":"2014","unstructured":"Roemer T, Krysan DJ (2014) Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med 4 pii:a019703","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"14_CR89","first-page":"257","volume":"1","author":"MH Saier Jr","year":"1999","unstructured":"Saier MH Jr, Beatty JT, Goffeau A, Harley KT, Heijne WHM, Huang SC et al (1999) The major facilitator superfamily. J Mol Microbiol Biotechnol 1:257\u2013279","journal-title":"J Mol Microbiol Biotechnol"},{"key":"14_CR90","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/AAC.43.11.2753","volume":"43","author":"D Sanglard","year":"1999","unstructured":"Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J (1999) The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 43:2753\u20132765","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR91","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1128\/AAC.47.8.2404-2412.2003","volume":"47","author":"D Sanglard","year":"2003","unstructured":"Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J (2003) Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 47:2404\u20132412","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR92","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","volume":"9","author":"D Sanglard","year":"2009","unstructured":"Sanglard D, Coste A, Ferrari S (2009) Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9:1029\u20131050","journal-title":"FEMS Yeast Res"},{"key":"14_CR93","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1128\/IAI.74.2.1352-1359.2006","volume":"74","author":"M Sanguinetti","year":"2006","unstructured":"Sanguinetti M, Posteraro B, La Sorda M, Torelli R, Fiori B, Santangelo R et al (2006) Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans. Infect Immun 74:1352\u20131359","journal-title":"Infect Immun"},{"key":"14_CR94","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1128\/AAC.00264-12","volume":"56","author":"C Sasse","year":"2012","unstructured":"Sasse C, Schillig R, Reimund A, Merk J, Morschh\u00e4user J (2012) Inducible and constitutive activation of two polymorphic promoter alleles of the Candida albicans multidrug efflux pump MDR1. Antimicrob Agents Chemother 56:4490\u20134494","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR95","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1128\/AAC.49.7.2994-2996.2005","volume":"49","author":"C Serena","year":"2005","unstructured":"Serena C, Fern\u00e1ndez-Torres B, Pastor FJ, Trilles L, Laz\u00e9ra Mdos S, Nolard N et al (2005) In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob Agents Chemother 49:2994\u20132996","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR96","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1128\/MMBR.00045-10","volume":"75","author":"RS Shapiro","year":"2011","unstructured":"Shapiro RS, Robbins N, Cowen LE (2011) Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev 75:213\u2013267","journal-title":"Microbiol Mol Biol Rev"},{"key":"14_CR97","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1128\/AAC.01497-08","volume":"53","author":"M Sharma","year":"2009","unstructured":"Sharma M, Manoharlal R, Shukla S, Puri N, Prasad T, Ambudkar SV et al (2009) Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals. Antimicrob Agents Chemother 53:3256\u20133265","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR98","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1042\/BSR20090151","volume":"30","author":"M Sharma","year":"2010","unstructured":"Sharma M, Manoharlal R, Puri N, Prasad R (2010) Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans. Biosci Rep 30:391\u2013404","journal-title":"Biosci Rep"},{"key":"14_CR99","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1567-1364.2010.00664.x","volume":"10","author":"W Shi","year":"2010","unstructured":"Shi W, Chen Z, Chen X, Cao L, Liu P, Sun S (2010) The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. FEMS Yeast Res 10:885\u2013893","journal-title":"FEMS Yeast Res"},{"key":"14_CR100","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1128\/AAC.05954-11","volume":"56","author":"T Shibata","year":"2012","unstructured":"Shibata T, Takahashi T, Yamada E, Kimura A, Nishikawa H, Hayakawa H et al (2012) T-2307 causes collapse of mitochondrial membrane potential in yeast. Antimicrob Agents Chemother 56:5892\u20135897","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR101","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/1389450003349209","volume":"1","author":"V St Georgiev","year":"2000","unstructured":"St Georgiev V (2000) Membrane transporters and antifungal drug resistance. Curr Drug Targets 1:261\u2013284","journal-title":"Curr Drug Targets"},{"key":"14_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.62.1.1-34.1998","volume":"62","author":"SP Stephanie","year":"1998","unstructured":"Stephanie SP, Paulsen IT, Saier MH Jr (1998) Major facilitator superfamily. Microbiol Mol Biol Rev 62:1\u201334","journal-title":"Microbiol Mol Biol Rev"},{"key":"14_CR103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0378-1119(97)00421-6","volume":"201","author":"SJ Thornewell","year":"1997","unstructured":"Thornewell SJ, Peery RB, Skatrud PL (1997) Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins. Gene 201:21\u201329","journal-title":"Gene"},{"key":"14_CR104","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/jac\/dkp429","volume":"65","author":"S Tobudic","year":"2010","unstructured":"Tobudic S, Kratzer C, Lassnigg A, Graninger W, Presterl E (2010a) In vitro activity of antifungal combinations against Candida albicans biofilms. J Antimicrob Chemother 65:271\u2013274","journal-title":"J Antimicrob Chemother"},{"key":"14_CR105","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1439-0507.2009.01690.x","volume":"53","author":"S Tobudic","year":"2010","unstructured":"Tobudic S, Lassnigg A, Kratzer C, Graninger W, Presterl E (2010b) Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. Mycoses 53:208\u2013214","journal-title":"Mycoses"},{"key":"14_CR106","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2958.2008.06143.x","volume":"68","author":"R Torelli","year":"2008","unstructured":"Torelli R, Posteraro B, Ferrari S, La Sorda M, Fadda G, Sanglard D et al (2008) The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata. Mol Microbiol 68:186\u2013201","journal-title":"Mol Microbiol"},{"key":"14_CR107","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.01397-07","volume":"52","author":"P Uppuluri","year":"2008","unstructured":"Uppuluri P, Nett J, Heitman J, Andes D (2008) Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52:1127\u20131132","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR108","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1128\/AAC.37.10.2101","volume":"37","author":"H Vanden Bossche","year":"1993","unstructured":"Vanden Bossche H, Marichal P, Le Jeune L, Coene MC, Gorrens J, Cools W (1993) Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrob Agents Chemother 37:2101\u20132105","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR109","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1128\/AAC.01510-06","volume":"51","author":"P Vandeputte","year":"2007","unstructured":"Vandeputte P, Tronchin G, Berge`s T, Hennequin C, Chabasse D, Bouchara JP (2007) Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth. Antimicrob Agents Chemother 51:982\u2013990","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR110","doi-asserted-by":"publisher","first-page":"713687","DOI":"10.1155\/2012\/713687","volume":"2012","author":"P Vandeputte","year":"2012","unstructured":"Vandeputte P, Ferrari S, Coste AT (2012) Antifungal resistance and new strategies to control fungal infections. Int J Microbiol 2012:713687","journal-title":"Int J Microbiol"},{"key":"14_CR111","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tplants.2008.02.001","volume":"13","author":"PJ Verrier","year":"2008","unstructured":"Verrier PJ, Bird D, Burla B, Dassa E, Forestier C, Geisler M et al (2008) Plant ABC proteins\u2014a unified nomenclature and updated inventory. Trends Plant Sci 13:151\u2013159","journal-title":"Trends Plant Sci"},{"key":"14_CR112","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1471-2180-9-167","volume":"14","author":"H Wang","year":"2009","unstructured":"Wang H, Kong F, Sorrell TC, Wang B, McNicholas P, Pantarat N et al (2009) Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing. BMC Microbiol 14:167","journal-title":"BMC Microbiol"},{"key":"14_CR113","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1042\/BST0331215","volume":"33","author":"TC White","year":"2005","unstructured":"White TC, Silver PM (2005) Regulation of sterol metabolism in Candida albicans by the UPC2 gene. Biochem Soc Trans 33:1215\u20131218","journal-title":"Biochem Soc Trans"},{"key":"14_CR114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","volume":"11","author":"TC White","year":"1998","unstructured":"White TC, Marr KA, Bowden RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11:382\u2013402","journal-title":"Clin Microbiol Rev"},{"key":"14_CR115","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1128\/AAC.46.6.1704-1713.2002","volume":"46","author":"TC White","year":"2002","unstructured":"White TC, Holleman S, Dy F, Mirels LF, Stevens DA (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46:1704\u20131713","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR116","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1128\/AAC.04228-14","volume":"59","author":"NP Wiederhold","year":"2015","unstructured":"Wiederhold NP, Najvar LK, Fothergill AW, Bocanegra R, Olivo M, McCarthy DI et al (2015) The Novel Arylamidine T-2307 Maintains In Vitro and In Vivo Activity against Echinocandin-Resistant Candida albicans. Antimicrob Agents Chemother 59:1341\u20131343","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR117","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1128\/AAC.47.9.2717-2724.2003","volume":"47","author":"LY Young","year":"2003","unstructured":"Young LY, Hull CM, Heitman J (2003) Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob Agents Chemother 47:2717\u20132724","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR118","doi-asserted-by":"publisher","first-page":"e1000939","DOI":"10.1371\/journal.ppat.1000939","volume":"6","author":"YQ Zhang","year":"2010","unstructured":"Zhang YQ, Gamarra S, Garcia-Effron G, Park S, Perlin DS, Rao R (2010) Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs. PLoS Pathog 6:e1000939","journal-title":"PLoS Pathog"}],"container-title":["Advances in Experimental Medicine and Biology","Yeast Membrane Transport"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-25304-6_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T07:35:14Z","timestamp":1599982514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-25304-6_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319253022","9783319253046"],"references-count":115,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-25304-6_14","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-319-25304-6","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}